| Ms Sheela Mathew, MS,FNP | |
|
1055 Portion Rd, Suit 11w, Farmingville, NY 11738-2299 | |
| (631) 736-4321 | |
| Not Available |
| Full Name | Ms Sheela Mathew |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Family Health |
| Location | 1055 Portion Rd, Farmingville, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922353267 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | F337416 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sheela Mathew, MS,FNP 1055 Portion Rd, Suit 11w, Farmingville, NY 11738-2299 Ph: (631) 736-4321 | Ms Sheela Mathew, MS,FNP 1055 Portion Rd, Suit 11w, Farmingville, NY 11738-2299 Ph: (631) 736-4321 |
News Archive
Yale University has launched a multicenter clinical trial, sponsored by Stand Up to Cancer and Melanoma Research Alliance, that will apply the latest in personalized medicine technology to treat metastatic melanoma. The trial, for which Yale is a lead site, will enroll patients lacking a particular genetic mutation for whom immune therapy did not work or was not an option.
Many terminally-ill patients cannot die at home because of a lack of services and training in palliative care, say researchers from the University of Warwick.
Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanapt™ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.
A report released today at the World Heart Federation World Congress of Cardiology in Dubai reveals significant gaps in public awareness regarding the cardiovascular risks of tobacco use and secondhand smoke. The report, entitled "Cardiovascular harms from tobacco use and secondhand smoke", was commissioned by the World Heart Federation and written by the International Tobacco Control Project (ITC Project), in collaboration with the Tobacco Free Initiative at the World Health Organization.
Researchers at the University of Utah compared the therapeutic potential of umbilical cord-derived sub-epithelial cells (UC-SECs), bone marrow-derived mesenchymal stem cells (BM-MSCs) and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) - all derived from human tissue - along with genes (S100a1 and SDF-1a) and growth factor (VEGF165) to evaluate how injected biologics might enhance cardiac function in mice modeled with myocardial infarction (MI; commonly referred to as heart attack).
› Verified 9 days ago